3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Ewing's Sarcoma: new trials by email Literature Review of Ewing's Sarcoma trials Research Report on Ewing's Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma Irinotecan, Vincristine, Temozolomide - Bone Cancer, Ewing's Sarcoma | Phase 2 | Terminated | Stanford University | 3 | 2011-05-01 | 2017-11-24 |
| Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT) VCR, CTX, ADM; IFO, VP-16 - Ewing's Sarcoma | Phase 2 | Terminated | Fudan University | 10 | 2007-03-01 | 2009-07-07 |
| Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients Vincristine, Doxorubicin, Cyclophosphamide - Ewing's Sarcoma | Phase 2 | Terminated | M.D. Anderson Cancer Center | 46 | 1997-11-01 | 2020-01-29 |
Sarcoma, Ewing (3) · Bone Neoplasms (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Bone Tissue (3) · Neoplasms, Connective Tissue (3) · Neoplasms, Connective and Soft Tissue (3) · Osteosarcoma (3) · Sarcoma (3) · Bone Diseases (1) · Musculoskeletal Diseases (1) · Neoplasms by Site (1)
Cyclophosphamide (2) · Doxorubicin (2) · Vincristine (2) · Dexrazoxane (1) · Etoposide (1) · Irinotecan (1) · Temozolomide (1) · disaccharide tripeptide (1) · pegfilgrastim (1)
Fudan University (1) · M.D. Anderson Cancer Center (1) · Stanford University (1)
United States (2) · China (1)
Eugenie S. Kleinerman, MD (1) · Kristen N. Ganjoo (1) · Ye Guo, M.D. (1)